General MedicationsINJECTIONGeneric
EPIRUBICIN HYDROCHLORIDE
EPIRUBICIN HYDROCHLORIDE
Standard Dose
150MG/75ML (2MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview EPIRUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 065408 (ANDA).
Marketing status: Discontinued Active ingredient EPIRUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 150MG/75ML (2MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2007-10-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPIRUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 065408 (ANDA). Marketing status: Discontinued Active ingredient EPIRUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 150MG/75ML (2MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2007-10-15 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.